Novartis AG - Strategy, SWOT and Corporate Finance Report
Novartis AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Novartis (or 'the company') is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is engaged in the research, development, manufacture and marketing of medicines, eye care products and generic pharmaceuticals. The company operates in more than 180 countries. It is headquartered in Basel, Switzerland, and employed 118,700 people as of December 31, 2015.
Detailed information on Novartis AG required for business and competitor intelligence needs.
A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis.
An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments.
Intelligence on Novartis AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors.
News about Novartis AG, such as business expansion, restructuring, and contract wins.
Large number of easy-to-grasp charts and graphs that present important data and key trends.
Reasons to buy
Gain understanding of Novartis AG and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Novartis AG as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Novartis AG's business structure, strategy and prospects.